Spruce Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	22	119	26	105	564	-
Market Cap Growth	-63.18%	361.35%	-75.29%	-81.46%	-	-
Enterprise Value	-56	27	-47	22	413	1
PE Ratio	-	-2.49	-0.56	-2.47	-19.10	-
PS Ratio	2.13	11.82	-	-	-	-
PB Ratio	0.32	1.56	0.38	0.94	3.78	-
P/FCF Ratio	-0.89	-3.58	-0.62	-2.91	-20.45	-
P/OCF Ratio	-0.89	-3.58	-0.62	-2.92	-20.51	-
EV/Sales Ratio	-4.44	2.71	-	-	-	-
EV/EBITDA Ratio	0.95	-0.58	1.04	-0.53	-14.19	-0.04
EV/EBIT Ratio	0.95	-0.58	1.03	-0.52	-14.14	-0.04
EV/FCF Ratio	1.23	-0.82	1.13	-0.61	-14.97	-0.04
Debt / Equity Ratio	0.06	0.06	0.09	0.06	0.04	-0.15
Debt / EBITDA Ratio	-0.08	-0.09	-0.14	-0.15	-0.21	-0.34
Debt / FCF Ratio	-0.11	-0.13	-0.15	-0.17	-0.22	-0.35
Quick Ratio	4.41	3.94	6.35	10.03	16.12	0.91
Current Ratio	4.67	4.18	6.72	10.36	16.43	1.08
Asset Turnover	0.09	0.08	0	0	0	0
Interest Coverage	-	-98.21	-108.95	-121.59	-90.45	-200.35
Return on Equity (ROE)	-57.50%	-52.30%	-54.90%	-33.70%	-49.70%	54.00%
Return on Assets (ROA)	-43.40%	-39.80%	-46.10%	-30.30%	-35.30%	-276.50%
Return on Capital (ROIC)	-72.93%	-64.29%	-63.33%	-35.79%	-18.91%	50.04%
Earnings Yield	-216.35%	-40.17%	-178.61%	-40.41%	-5.23%	-
FCF Yield	-168.67%	-27.90%	-161.25%	-34.37%	-4.89%	-
Buyback Yield / Dilution	-28.83%	-63.68%	-0.71%	-289.93%	-683.77%	84.44%
Total Shareholder Return	-28.83%	-63.68%	-0.71%	-289.93%	-683.77%	84.44%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).